Organovo Holdings, Inc. Stock price
Is Organovo Holdings, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Organovo Holdings, Inc. Stock Analysis
Analyst Opinions
7 Analysts have issued a Organovo Holdings, Inc. forecast:
Analyst Opinions
7 Analysts have issued a Organovo Holdings, Inc. forecast:
Don't miss a Thing! We will send you all news about Organovo Holdings, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
| Head office | United States |
| CEO | Keith Murphy |
| Employees | 14 |
| Founded | 2012 |
| Website | organovo.com |


